AskAt Inc. announced today that the company received a use patent allowance of its 5-HT4 receptor agonist (AAT-009) for dementia. Application No. BR112012020060.7 was published in Brazilian Industrial Property Journal (Official Gazette) No: 2621 on March 30, 2021. In addition to Brazil, the use patent has been granted in Canada, Europe, Japan, Korea, Mexico, Russia, and the U.S.